APLEVANT 1.5mg (Dulaglutide PFS) 1.5mg

APLEVANT 1.5mg (dulaglutide) is an injectable medication used to support blood sugar management in adults with type 2 diabetes. This pre-filled syringe form delivers a consistent dose for convenient weekly administration. A trusted option for diabetes care, it helps maintain glucose levels when combined with diet and exercise.

Strength

1.5mg

Manufacturer / TM Owner

Eli Lilly

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APLEVANT 1.5mg (dulaglutide) is prescribed to improve blood sugar control in adults with type 2 diabetes. It works alongside diet and exercise to help regulate glucose levels over time. This medication is often used when oral medications alone are not sufficient to maintain target blood sugar ranges.

Side Effects

APLEVANT 1.5mg may help reduce frequent hunger and support steady energy levels throughout the day. Some users notice improved appetite control and fewer sugar cravings after consistent use. The effects develop gradually with regular weekly injections.

Precautions & Warnings

Store APLEVANT 1.5mg in the refrigerator until use, but avoid freezing. Keep the pen or syringe away from direct light and heat. Always check the liquid clarity and expiration date before injecting. Dispose of used needles in a sharps container as directed.

Avoid Interactions

APLEVANT 1.5mg may interact with medications that affect digestion or blood sugar levels, including insulin and oral diabetes drugs. Alcohol use may increase the risk of low blood sugar when combined with this medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

APLEVANT 1.5mg is used to help manage blood sugar levels in adults with type 2 diabetes as part of a treatment plan.

APLEVANT 1.5mg is typically administered once weekly via subcutaneous injection.

Common effects may include nausea, stomach discomfort, or reduced appetite, especially when starting treatment.

It may be used with other diabetes medications, but your healthcare provider should monitor your response.

Store APLEVANT 1.5mg in the refrigerator and protect it from freezing or direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.